News

• Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
  02/04/2022 / 07:30 - GlobeNewswire
•  
• Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise Lombardo
  11/09/2021 / 14:55 - GlobeNewswire
•  
• Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
  09/23/2021 / 07:00 - GlobeNewswire
•  
• Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
  09/17/2021 / 13:45 - GlobeNewswire
•  
• Innate Pharma Reports First Half 2021 Financial Results and Business Update
  09/15/2021 / 07:00 - GlobeNewswire
•  
• Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
  09/07/2021 / 07:00 - GlobeNewswire
•  
• Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress
  09/02/2021 / 08:00 - GlobeNewswire
•  
• Innate Pharma to Participate in Upcoming Investor Conferences
  08/30/2021 / 07:00 - GlobeNewswire
•  
• Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021
  08/11/2021 / 07:00 - GlobeNewswire
•  
• NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021
  07/12/2021 / 07:00 - GlobeNewswire
•  
• Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021
  07/12/2021 / 07:00 - GlobeNewswire
•  
• Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia
  07/06/2021 / 07:00 - GlobeNewswire
•  
• Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis Fungoides
  06/22/2021 / 13:00 - GlobeNewswire
•  
• Innate Pharma to Host Virtual Investor Event to Highlight Progress Against Company Strategy
  06/16/2021 / 07:00 - GlobeNewswire
•  
• Number of Shares and Voting Rights of Innate Pharma as of June 1, 2021
  06/14/2021 / 07:00 - GlobeNewswire